Greenville, NC, October 09, 2010 --(PR.com
)-- Joseph E. “Joe” Cobb Jr., senior formulations scientist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional™ (CPIP™) credential.
Awarded by the ISPE Professional Certification Commission, the CPIP credential is the only competency-based international certification for pharmaceutical professionals. It holds those who qualify to a global competency standard through demonstrated education, experience and a rigorous examination.
“Through their work and research, Metrics employees continually strive to advance scientific knowledge and understanding,” said Phil Hodges, president of Metrics Inc. “Their commitment to good science is reflected by their desire to exceed industry expectations and standards – just like Joe has done by earning CPIP certification. I congratulate Joe on his impressive achievement.”
As senior formulations scientist, Cobb manages all aspects of projects at Metrics that involve early-phase solid oral dosage development. Some of those projects involve novel delivery systems such as rapid-dissolve technologies, modified release tablets and multi-particulate applications.
With nearly 20 years of industry experience, Cobb joined Metrics in 2002, where he oversees formulation development, scale-up and commercial process validation for new drug application (NDA) and investigational new drug application (IND) submissions.
The holder of a U.S. patent for a pharmaceutical application, Cobb has authored several posters presented during annual conferences of the American Association of Pharmaceutical Sciences. He received his bachelor’s of science degree in chemical engineering from The Ohio State University.
Metrics Inc. is one of the most respected contract pharmaceutical development and manufacturing companies in the United States today.
Started as an analytical laboratory in 1994, Metrics has evolved into a full-service provider of quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical material manufacturing (CTM) for Phase I, II and III trials; commercial manufacturing; and analytical method development and validation services.
Metrics has particular expertise in FTIM and Phase I, II, and III studies, having conducted more than 120 FTIM studies for different chemical entities in the last five years alone – while developing more than 700 batches of CTM in the same period.
The International Society of Pharmaceutical Engineers (ISPE) is an independent membership organization of 22,000 pharmaceutical manufacturing professionals from 90 countries. ISPE aims to be the catalyst for engineering pharmaceutical innovation by providing members opportunities to develop technical knowledge, exchange practical experience within their community, enhance their professional skills and collaborate with global regulatory agencies and industry leaders.
The ISPE Professional Certification Commission is an autonomous governing body that develops certification programs to benefit professionals and their employers, as well as government, academe and the public health product consumer. The PCC’s commissioners include senior-level industry professionals, academic leaders, representatives from government regulatory agencies and members of the general public.